BACKGROUND: Inherited retinal degenerations (IRDs) are a common cause of visual disturbance with a high clinical and genetic heterogeneity. Recent sequencing techniques such as whole exome sequencing (WES) contribute to the discovery of novel genes. The aim of the current study was to use WES data to identify large deletions that include at least one exon in known IRD genes. METHODS: Patients diagnosed with IRDs underwent a comprehensive ophthalmic evaluation. WES was performed using the NimbleGen V2 paired-end kit and HiSeq 2000. An analysis of exon coverage data was performed on 60 WES samples. Exonic deletions were verified by 'PCR walking' analysis. RESULTS: We analysed data obtained from 60 WES samples of index patients with IRDs. By calculating the average coverage for all exons in the human genome, we were able to identify homozygous and hemizygous deletions of at least one exon in six families (10%), including a single-exon deletion in EYS, deletions of three consecutive exons in MYO7A and NPHP4, deletions of four and eight consecutive exons in RPGR and a multigene deletion on the X-chromosome, including CHM. By using PCR-walking analysis, we were able to identify the borders of five of the deletions and to screen our set of patients for these deletions. CONCLUSIONS: We performed here a comprehensive analysis of WES data as a tool for identifying large genomic deletions in patients with IRDs. Our analysis indicates that large deletions are relatively frequent (about 10% of our WES cohort) and should be screened when analysing WES data. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
BACKGROUND: Inherited retinal degenerations (IRDs) are a common cause of visual disturbance with a high clinical and genetic heterogeneity. Recent sequencing techniques such as whole exome sequencing (WES) contribute to the discovery of novel genes. The aim of the current study was to use WES data to identify large deletions that include at least one exon in known IRD genes. METHODS:Patients diagnosed with IRDs underwent a comprehensive ophthalmic evaluation. WES was performed using the NimbleGen V2 paired-end kit and HiSeq 2000. An analysis of exon coverage data was performed on 60 WES samples. Exonic deletions were verified by 'PCR walking' analysis. RESULTS: We analysed data obtained from 60 WES samples of index patients with IRDs. By calculating the average coverage for all exons in the human genome, we were able to identify homozygous and hemizygous deletions of at least one exon in six families (10%), including a single-exon deletion in EYS, deletions of three consecutive exons in MYO7A and NPHP4, deletions of four and eight consecutive exons in RPGR and a multigene deletion on the X-chromosome, including CHM. By using PCR-walking analysis, we were able to identify the borders of five of the deletions and to screen our set of patients for these deletions. CONCLUSIONS: We performed here a comprehensive analysis of WES data as a tool for identifying large genomic deletions in patients with IRDs. Our analysis indicates that large deletions are relatively frequent (about 10% of our WES cohort) and should be screened when analysing WES data. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Authors: Kristof Van Schil; Sarah Naessens; Stijn Van de Sompele; Marjolein Carron; Alexander Aslanidis; Caroline Van Cauwenbergh; Anja Kathrin Mayer; Mattias Van Heetvelde; Miriam Bauwens; Hannah Verdin; Frauke Coppieters; Michael E Greenberg; Marty G Yang; Marcus Karlstetter; Thomas Langmann; Katleen De Preter; Susanne Kohl; Timothy J Cherry; Bart P Leroy; Elfride De Baere Journal: Genet Med Date: 2017-07-27 Impact factor: 8.822
Authors: Jakub Piotr Fichna; Anna Macias; Marcin Piechota; Michał Korostyński; Anna Potulska-Chromik; Maria Jolanta Redowicz; Cezary Zekanowski Journal: Hum Genomics Date: 2018-07-03 Impact factor: 4.639
Authors: Erin Zampaglione; Benyam Kinde; Emily M Place; Daniel Navarro-Gomez; Matthew Maher; Farzad Jamshidi; Sherwin Nassiri; J Alex Mazzone; Caitlin Finn; Dana Schlegel; Jason Comander; Eric A Pierce; Kinga M Bujakowska Journal: Genet Med Date: 2020-02-10 Impact factor: 8.822
Authors: Giulia Ascari; Nanna D Rendtorff; Marieke De Bruyne; Julie De Zaeytijd; Michel Van Lint; Miriam Bauwens; Mattias Van Heetvelde; Gavin Arno; Julie Jacob; David Creytens; Jo Van Dorpe; Thalia Van Laethem; Toon Rosseel; Tim De Pooter; Peter De Rijk; Wouter De Coster; Björn Menten; Alfredo Dueñas Rey; Mojca Strazisar; Mette Bertelsen; Lisbeth Tranebjaerg; Elfride De Baere Journal: Front Cell Dev Biol Date: 2021-04-21
Authors: Caroline Van Cauwenbergh; Kristof Van Schil; Robrecht Cannoodt; Miriam Bauwens; Thalia Van Laethem; Sarah De Jaegere; Wouter Steyaert; Tom Sante; Björn Menten; Bart P Leroy; Frauke Coppieters; Elfride De Baere Journal: Genet Med Date: 2016-09-08 Impact factor: 8.822
Authors: G Jane Farrar; Matthew Carrigan; Adrian Dockery; Sophia Millington-Ward; Arpad Palfi; Naomi Chadderton; Marian Humphries; Anna Sophia Kiang; Paul F Kenna; Pete Humphries Journal: Hum Mol Genet Date: 2017-08-01 Impact factor: 6.150
Authors: Jamie M Ellingford; Bradley Horn; Christopher Campbell; Gavin Arno; Stephanie Barton; Catriona Tate; Sanjeev Bhaskar; Panagiotis I Sergouniotis; Rachel L Taylor; Keren J Carss; Lucy F L Raymond; Michel Michaelides; Simon C Ramsden; Andrew R Webster; Graeme C M Black Journal: J Med Genet Date: 2017-10-26 Impact factor: 6.318